EMA Application withdrawn: Memantine FGK (memantine) — FGK Representative Service GmbH

View source ↗

Summary

The EMA application for Memantine FGK (memantine) has been withdrawn by FGK Representative Service GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine FGK (memantine)

Snippet

Status: Application withdrawn. Therapeutic area: Alzheimer Disease. MAH: FGK Representative Service GmbH. Decision date: 18/01/2013. Conditional approval